Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Expert Opinion on Biological Therapy
|
January 8, 2013
Is specific HIV eradication from the brain possible or needed?
Bruce J Brew, Lachlan Gray, Sharon Lewin, et al.
Retrovirology
|
June 4, 2011
Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
Lachlan Gray, Jasminka Sterjovski, Paul A Ramsland, et al.
Viral Immunology
|
January 5, 2007
CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy
Patricia Price, Niamh Keane, Lachlan Gray, et al.
Sexual Health
|
December 13, 2005
The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression
Paul R Gorry, Jasminka Sterjovski, Melissa Churchill, et al.
Genomics
|
November 23, 2018
Early transcriptome changes in response to chemical long-term potentiation induced via activation of synaptic NMDA receptors in mouse hippocampal neurons
Nicola Bliim, Iryna Leshchyns'ka, Ryan Keable, et al.
Scientific Reports
|
July 1, 2016
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
Khamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
Virology
|
April 13, 2010
Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry
Lamorris M Loftin, Martha F Kienzle, Yanjie Yi, et al.
Virology
|
May 27, 2005
Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome
Lachlan Gray, Jasminka Sterjovski, Melissa Churchill, et al.
Journal of Neurovirology
|
August 1, 2006
Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia
Melissa J Churchill, Anna Figueiredo, Daniel Cowley, et al.
AIDS (London, England)
|
November 6, 2013
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells
Fiona Wightman, Hao K Lu, Ajantha E Solomon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Expert Opinion on Biological Therapy
|
January 8, 2013
Is specific HIV eradication from the brain possible or needed?
Bruce J Brew, Lachlan Gray, Sharon Lewin, et al.
Retrovirology
|
June 4, 2011
Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
Lachlan Gray, Jasminka Sterjovski, Paul A Ramsland, et al.
Viral Immunology
|
January 5, 2007
CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy
Patricia Price, Niamh Keane, Lachlan Gray, et al.
Sexual Health
|
December 13, 2005
The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression
Paul R Gorry, Jasminka Sterjovski, Melissa Churchill, et al.
Genomics
|
November 23, 2018
Early transcriptome changes in response to chemical long-term potentiation induced via activation of synaptic NMDA receptors in mouse hippocampal neurons
Nicola Bliim, Iryna Leshchyns'ka, Ryan Keable, et al.
Scientific Reports
|
July 1, 2016
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
Khamis Tomusange, Danushka Wijesundara, Jason Gummow, et al.
Virology
|
April 13, 2010
Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry
Lamorris M Loftin, Martha F Kienzle, Yanjie Yi, et al.
Virology
|
May 27, 2005
Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome
Lachlan Gray, Jasminka Sterjovski, Melissa Churchill, et al.
Journal of Neurovirology
|
August 1, 2006
Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia
Melissa J Churchill, Anna Figueiredo, Daniel Cowley, et al.
AIDS (London, England)
|
November 6, 2013
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells
Fiona Wightman, Hao K Lu, Ajantha E Solomon, et al.
Page
of 2